Ropes & Gray represented Georgiamune Inc. in its exclusive worldwide license and collaboration agreement with The Menarini Group for GIM-621, a preclinical-stage, first-in-class oral small molecule ...
Ropes & Gray represented Vitruvian Partners as lead investor in a $600 million equity financing for Angle Health, an AI-native healthcare benefits platform for employers, at a $2.7 billion valuation.
Mergermarket quoted private equity partner Eric Issadore in an article on the AI dealmaking environment as data shows AI M&A ...
Ropes & Gray represented Clinical ink and GI Partners in a strategic investment in Clinical ink by Ardan Equity and GI Partners. In the deal, existing investors fully exited their prior investments, ...
In a recent Mergermarket article profiling the growing push for specialization and differentiation in GP-led secondaries, ...
Eli Lilly Enters Drug Delivery Collaboration with Hong Kong’s Metis TechBio Worth up to $1.1 Billion
Ropes & Gray advised Eli Lilly in a collaboration with Hong Kong-based Metis TechBio worth up to $1.1 billion to research and develop tissue-specific drug delivery technologies using novel lipid ...
Ropes & Gray represented Musixmatch in its acquisition of Music Reports Inc., a provider of objective music rights data and administration services. The transaction was announced on Oct. 19. Financial ...
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s ...
Ropes & Gray represented Heartland Dental in its affiliation with Foundation Dental Partners, a doctor-focused dental support ...
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results